1. Home
  2. CRL vs MKSI Comparison

CRL vs MKSI Comparison

Compare CRL & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • MKSI
  • Stock Information
  • Founded
  • CRL 1947
  • MKSI 1961
  • Country
  • CRL United States
  • MKSI United States
  • Employees
  • CRL N/A
  • MKSI N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • MKSI Industrial Machinery/Components
  • Sector
  • CRL Health Care
  • MKSI Industrials
  • Exchange
  • CRL Nasdaq
  • MKSI Nasdaq
  • Market Cap
  • CRL 7.3B
  • MKSI 7.1B
  • IPO Year
  • CRL 2000
  • MKSI 1999
  • Fundamental
  • Price
  • CRL $156.68
  • MKSI $100.22
  • Analyst Decision
  • CRL Buy
  • MKSI Buy
  • Analyst Count
  • CRL 14
  • MKSI 11
  • Target Price
  • CRL $186.00
  • MKSI $121.55
  • AVG Volume (30 Days)
  • CRL 1.1M
  • MKSI 1.1M
  • Earning Date
  • CRL 08-06-2025
  • MKSI 08-06-2025
  • Dividend Yield
  • CRL N/A
  • MKSI 0.88%
  • EPS Growth
  • CRL N/A
  • MKSI 3206.74
  • EPS
  • CRL N/A
  • MKSI 3.95
  • Revenue
  • CRL $4,028,615,000.00
  • MKSI $3,741,000,000.00
  • Revenue This Year
  • CRL N/A
  • MKSI $7.17
  • Revenue Next Year
  • CRL $2.49
  • MKSI $6.66
  • P/E Ratio
  • CRL N/A
  • MKSI $25.38
  • Revenue Growth
  • CRL N/A
  • MKSI 4.50
  • 52 Week Low
  • CRL $91.86
  • MKSI $54.84
  • 52 Week High
  • CRL $230.02
  • MKSI $125.33
  • Technical
  • Relative Strength Index (RSI)
  • CRL 47.73
  • MKSI 51.54
  • Support Level
  • CRL $145.99
  • MKSI $97.62
  • Resistance Level
  • CRL $168.61
  • MKSI $106.19
  • Average True Range (ATR)
  • CRL 5.10
  • MKSI 3.91
  • MACD
  • CRL -1.68
  • MKSI 0.54
  • Stochastic Oscillator
  • CRL 31.41
  • MKSI 66.27

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About MKSI MKS Instruments Inc.

MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

Share on Social Networks: